{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T17:44:43Z","timestamp":1774633483351,"version":"3.50.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T00:00:00Z","timestamp":1686182400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T00:00:00Z","timestamp":1686182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s00198-023-06789-5","type":"journal-article","created":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T03:26:22Z","timestamp":1686194782000},"page":"1535-1548","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Osteoporosis medication adherence tools: a systematic review"],"prefix":"10.1007","volume":"34","author":[{"given":"Elahe","family":"Hesari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2992-6184","authenticated-orcid":false,"given":"Mahnaz","family":"Sanjari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Javad","family":"Mansourzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noushin","family":"Fahimfar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazem","family":"Khalagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arash","family":"Ghazbani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afshin","family":"Ostovar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akbar","family":"Fotouhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,8]]},"reference":[{"issue":"2","key":"6789_CR1","first-page":"92","volume":"43","author":"KN Tu","year":"2018","unstructured":"Tu KN, Lie JD, Wan CKV, Cameron M, Austel AG, Nguyen JK et al (2018) Osteoporosis: a review of treatment options. Pharm Ther 43(2):92","journal-title":"Pharm Ther"},{"issue":"11","key":"6789_CR2","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1056\/NEJM199803123381107","volume":"338","author":"R Eastell","year":"1998","unstructured":"Eastell R (1998) Treatment of postmenopausal osteoporosis. N Engl J Med 338(11):736\u2013746","journal-title":"N Engl J Med"},{"issue":"2","key":"6789_CR3","first-page":"132","volume":"12","author":"E FallahMehrabadi","year":"2017","unstructured":"FallahMehrabadi E, Pakgohar M, Asadi S, Haghani H (2017) Lifestyle of elderly people with osteoporosis and its related factors. Iranian J Ageing 12(2):132\u2013145","journal-title":"Iranian J Ageing"},{"issue":"1","key":"6789_CR4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.5339\/jlghs.2016.2","volume":"2016","author":"R Vijayakumar","year":"2016","unstructured":"Vijayakumar R, B\u00fcsselberg D (2016) Osteoporosis: an under-recognized public health problem: local and global risk factors and its regional and worldwide prevalence. J Local Global Health Sci 2016(1):2","journal-title":"J Local Global Health Sci"},{"issue":"9319","key":"6789_CR5","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1016\/S0140-6736(02)08657-9","volume":"359","author":"SR Cummings","year":"2002","unstructured":"Cummings SR, Melton LJ (2002) Epidemiology and outcomes of osteoporotic fractures. The Lancet 359(9319):1761\u20131767","journal-title":"The Lancet"},{"issue":"3","key":"6789_CR6","doi-asserted-by":"publisher","first-page":"229","DOI":"10.4103\/cmi.cmi_60_20","volume":"18","author":"P Gupta","year":"2020","unstructured":"Gupta P, Johnson JT, Cherian KE, Asha HS, Kapoor N, Paul TV (2020) Secondary osteoporosis: case-based review. Curr Med Issues 18(3):229","journal-title":"Curr Med Issues"},{"key":"6789_CR7","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jpsychores.2019.03.184","volume":"122","author":"B Nie","year":"2019","unstructured":"Nie B, Chapman SC, Chen Z, Wang X, Wei L (2019) Utilization of the beliefs about medicine questionnaire and prediction of medication adherence in China: a systematic review and meta-analysis. J Psychosom Res 122:54\u201368","journal-title":"J Psychosom Res"},{"key":"6789_CR8","unstructured":"Rosen CJ (2020) The epidemiology and pathogenesis of osteoporosis. In: Feingold KR, Anawalt B, Blackman MR et al (eds) Endotext [Internet]. MDText.com, Inc., South Dartmouth, MA. Available from: https:\/\/www.ncbi.nlm.nih.gov\/sites\/books\/NBK279134\/"},{"issue":"1","key":"6789_CR9","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2165\/00002512-200724010-00003","volume":"24","author":"A Papaioannou","year":"2007","unstructured":"Papaioannou A, Kennedy CC, Dolovich L, Lau E, Adachi JD (2007) Patient adherence to osteoporosis medications. Drugs Aging 24(1):37\u201355","journal-title":"Drugs Aging"},{"issue":"11","key":"6789_CR10","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1007\/s00198-006-0179-x","volume":"17","author":"D Weycker","year":"2006","unstructured":"Weycker D, Macarios D, Edelsberg J, Oster G (2006) Compliance with drug therapy for postmenopausal osteoporosis. Osteoporos Int 17(11):1645\u20131652","journal-title":"Osteoporos Int"},{"issue":"12","key":"6789_CR11","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/S0025-6196(11)61093-8","volume":"82","author":"P Kothawala","year":"2007","unstructured":"Kothawala P, Badamgarav E, Ryu S, Miller RM, Halbert R (2007) Systematic review and meta-analysis of real-world adherence to drug therapy for osteoporosis. Mayo Clin Proc 82(12):1493\u2013501","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"6789_CR12","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00198-019-05228-8","volume":"31","author":"J Morley","year":"2020","unstructured":"Morley J, Moayyeri A, Ali L, Taylor A, Feudjo-Tepie M, Hamilton L et al (2020) Persistence and compliance with osteoporosis therapies among postmenopausal women in the UK Clinical Practice Research Datalink. Osteoporos Int 31(3):533\u2013545","journal-title":"Osteoporos Int"},{"issue":"1","key":"6789_CR13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11657-020-00872-8","volume":"16","author":"N Fahimfar","year":"2021","unstructured":"Fahimfar N, Noorali S, Yousefi S, Gharibzadeh S, Shafiee G, Panahi N et al (2021) Prevalence of osteoporosis among the elderly population of Iran. Arch Osteoporos 16(1):16","journal-title":"Arch Osteoporos"},{"key":"6789_CR14","doi-asserted-by":"crossref","unstructured":"Addo B, Sencherey S, Babayara MNK (2018) Medication noncompliance among patients with chronic diseases attending a primary health facility in a Periurban District in Ghana. Int J Chron Dis 2018:7187284","DOI":"10.1155\/2018\/7187284"},{"issue":"12","key":"6789_CR15","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1007\/s00198-018-4759-3","volume":"29","author":"C Yeam","year":"2018","unstructured":"Yeam C, Chia S, Tan H, Kwan Y, Fong W, Seng J (2018) A systematic review of factors affecting medication adherence among patients with osteoporosis. Osteoporos Int 29(12):2623\u20132637","journal-title":"Osteoporos Int"},{"issue":"2","key":"6789_CR16","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1586\/erp.12.8","volume":"12","author":"M Hiligsmann","year":"2012","unstructured":"Hiligsmann M, Boonen A, Rabenda V, Reginster J-Y (2012) The importance of integrating medication adherence into pharmacoeconomic analyses: the example of osteoporosis. Expert Rev Pharmacoecon Outcomes Res 12(2):159\u2013166","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"1","key":"6789_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12875-020-01103-2","volume":"21","author":"P Naik-Panvelkar","year":"2020","unstructured":"Naik-Panvelkar P, Norman S, Elgebaly Z, Elliott J, Pollack A, Thistlethwaite J et al (2020) Osteoporosis management in Australian general practice: an analysis of current osteoporosis treatment patterns and gaps in practice. BMC Fam Pract 21(1):1\u201313","journal-title":"BMC Fam Pract"},{"issue":"2","key":"6789_CR18","doi-asserted-by":"publisher","first-page":"e0171863","DOI":"10.1371\/journal.pone.0171863","volume":"12","author":"M Alsous","year":"2017","unstructured":"Alsous M, Alhalaiqa F, Abu Farha R, Abdel Jalil M, McElnay J, Horne R (2017) Reliability and validity of Arabic translation of Medication Adherence Report Scale (MARS) and Beliefs about Medication Questionnaire (BMQ)\u2013specific for use in children and their parents. PLoS ONE 12(2):e0171863","journal-title":"PLoS ONE"},{"issue":"11","key":"6789_CR19","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1007\/s00198-020-05507-9","volume":"31","author":"G Koller","year":"2020","unstructured":"Koller G, Goetz V, Vandermeer B, Homik J, McAlister F, Kendler D et al (2020) Persistence and adherence to parenteral osteoporosis therapies: a systematic review. Osteo Int 31(11):2093\u2013102","journal-title":"Osteo Int"},{"issue":"7","key":"6789_CR20","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1177\/1759720X18785539","volume":"10","author":"A Jaleel","year":"2018","unstructured":"Jaleel A, Saag KG, Danila MI (2018) Improving drug adherence in osteoporosis: an update on more recent studies. Ther Adv Musculoskelet Dis 10(7):141\u2013149","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"1","key":"6789_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11657-019-0633-y","volume":"14","author":"A Senay","year":"2019","unstructured":"Senay A, Fernandes JC, Delisle J, Morin SN, Perreault S (2019) Persistence and compliance to osteoporosis therapy in a fracture liaison service: a prospective cohort study. Arch Osteoporos 14(1):1\u201311","journal-title":"Arch Osteoporos"},{"issue":"1","key":"6789_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s40273-017-0570-9","volume":"36","author":"A Monnette","year":"2018","unstructured":"Monnette A, Zhang Y, Shao H, Shi L (2018) Concordance of adherence measurement using self-reported adherence questionnaires and medication monitoring devices: an updated review. Pharmacoeconomics 36(1):17\u201327","journal-title":"Pharmacoeconomics"},{"issue":"11","key":"6789_CR23","doi-asserted-by":"publisher","first-page":"e013375","DOI":"10.1136\/bmjopen-2016-013375","volume":"6","author":"A La Caze","year":"2016","unstructured":"La Caze A, Cottrell N (2016) Validated adherence scales used in a measurement-guided medication management approach to target and tailor a medication adherence intervention: a randomised controlled trial. BMJ Open 6(11):e013375","journal-title":"BMJ Open"},{"key":"6789_CR24","doi-asserted-by":"publisher","first-page":"419","DOI":"10.2147\/PPA.S175353","volume":"13","author":"MJ Ahmadizadeh","year":"2019","unstructured":"Ahmadizadeh MJ, Ebadi A (2019) Development and psychometric evaluation of the treatment adherence questionnaire for patients with combat post-traumatic stress disorder. Patient Prefer Adherence 13:419","journal-title":"Patient Prefer Adherence"},{"key":"6789_CR25","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.2147\/PPA.S200058","volume":"13","author":"L Al-Hassany","year":"2019","unstructured":"Al-Hassany L, Kloosterboer SM, Dierckx B, Koch BC (2019) Assessing methods of measuring medication adherence in chronically ill children\u2013a narrative review. Patient Prefer Adherence 13:1175","journal-title":"Patient Prefer Adherence"},{"key":"6789_CR26","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jsat.2015.05.002","volume":"57","author":"AL McRae-Clark","year":"2015","unstructured":"McRae-Clark AL, Baker NL, Sonne SC, DeVane CL, Wagner A, Norton J (2015) Concordance of direct and indirect measures of medication adherence in a treatment trial for cannabis dependence. J Subst Abuse Treat 57:70\u201374","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"6789_CR27","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/00005650-198601000-00007","volume":"24","author":"DE Morisky","year":"1986","unstructured":"Morisky DE, Green LW, Levine DM (1986) Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 24(1):67\u201374","journal-title":"Med Care"},{"issue":"6","key":"6789_CR28","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1111\/jep.12773","volume":"23","author":"AC Cabral","year":"2017","unstructured":"Cabral AC, Moura-Ramos M, Castel-Branco M, Caramona M, Fernandez-Llimos F, Figueiredo IV (2017) Influence of the mode of administration on the results of medication adherence questionnaires. J Eval Clin Pract 23(6):1252\u20131257","journal-title":"J Eval Clin Pract"},{"issue":"7","key":"6789_CR29","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1111\/bcp.14193","volume":"86","author":"AHY Chan","year":"2020","unstructured":"Chan AHY, Horne R, Hankins M, Chisari C (2020) The medication adherence report scale: a measurement tool for eliciting patients\u2019 reports of nonadherence. Br J Clin Pharmacol 86(7):1281\u20131288","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"6789_CR30","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1111\/j.1524-4733.2009.00543.x","volume":"12","author":"S Karve","year":"2009","unstructured":"Karve S, Cleves MA, Helm M, Hudson TJ, West DS, Martin BC (2009) Prospective validation of eight different adherence measures for use with administrative claims data among patients with schizophrenia. Value Health 12(6):989\u2013995","journal-title":"Value Health"},{"issue":"1","key":"6789_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2369-15-139","volume":"15","author":"BJ Foster","year":"2014","unstructured":"Foster BJ, Pai A, Zhao H, Furth S (2014) The TAKE-IT study: aims, design, and methods. BMC Nephrol 15(1):1\u20139","journal-title":"BMC Nephrol"},{"key":"6789_CR32","doi-asserted-by":"crossref","unstructured":"Lam WY, Fresco P (2015) Medication adherence measures: an overview. BioMed Res Int 2015:217047","DOI":"10.1155\/2015\/217047"},{"key":"6789_CR33","unstructured":"Medication Adherence and Persistence Special Interest Group 2021. Available from: https:\/\/www.ispor.org\/member-groups\/special-interest-groups\/medication-adherence-and-persistence.\u00a0Accessed 28 May 2022"},{"issue":"6","key":"6789_CR34","first-page":"371","volume":"86","author":"S Liu","year":"2006","unstructured":"Liu S, Liao E, Wu X, Cao X, Shan P, Su X (2006) Age-related and menopause-related changes of urinary excretion of C-and N-terminal cross-linked telopeptides of type I collagen and the relationships thereof with menopause-related bone loss. Zhonghua Yi Xue Za Zhi 86(6):371\u2013375","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"7","key":"6789_CR35","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1002\/jbmr.342","volume":"26","author":"R Eastell","year":"2011","unstructured":"Eastell R, Vrijens B, Cahall DL, Ringe JD, Garnero P, Watts NB (2011) Bone turnover markers and bone mineral density response with risedronate therapy: relationship with fracture risk and patient adherence. J Bone Mineral Res 26(7):1662\u20131669","journal-title":"J Bone Mineral Res"},{"key":"6789_CR36","unstructured":"Yamashita M (2016) Urinary cross-linked N-terminal telopeptide of type I collagen levels of infants with Osteogenesis Imperfecta and healthy infants"},{"issue":"12","key":"6789_CR37","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.clinbiochem.2012.03.035","volume":"45","author":"SP Chubb","year":"2012","unstructured":"Chubb SP (2012) Measurement of C-terminal telopeptide of type I collagen (CTX) in serum. Clin Biochem 45(12):928\u2013935","journal-title":"Clin Biochem"},{"issue":"7","key":"6789_CR38","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1002\/jbmr.342","volume":"26","author":"R Eastell","year":"2011","unstructured":"Eastell R, Vrijens B, Cahall DL, Ringe JD, Garnero P, Watts NB (2011) Bone turnover markers and bone mineral density response with risedronate therapy: relationship with fracture risk and patient adherence. J Bone Miner Res 26(7):1662\u20131669","journal-title":"J Bone Miner Res"},{"key":"6789_CR39","doi-asserted-by":"crossref","unstructured":"Geusens P, Hochberg MC, van der Voort DJ, Pols H, van der Klift M, Siris E et al (2002) editors. Performance of risk indices for identifying low bone density in postmenopausal women. Mayo Clinic Proceedings; Elsevier","DOI":"10.4065\/77.7.629"},{"key":"6789_CR40","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.2147\/PPA.S136890","volume":"11","author":"CM Sperber","year":"2017","unstructured":"Sperber CM, Samarasinghe SR, Lomax GP (2017) An upper and lower bound of the medication possession ratio. Patient Prefer Adherence 11:1469","journal-title":"Patient Prefer Adherence"},{"key":"6789_CR41","unstructured":"Nau DP (2012) Proportion of days covered (PDC) as a preferred method of measuring medication adherence. Pharmacy Quality Alliance,\u00a0Springfield, VA"},{"issue":"8","key":"6789_CR42","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/0895-7061(96)00056-8","volume":"9","author":"JY Lee","year":"1996","unstructured":"Lee JY, Kusek JW, Greene PG, Bernhard S, Norris K, Smith D et al (1996) Assessing medication adherence by pill count and electronic monitoring in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Am J Hypertens 9(8):719\u2013725","journal-title":"Am J Hypertens"},{"issue":"2","key":"6789_CR43","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0738-3991(98)00107-4","volume":"37","author":"BL Svarstad","year":"1999","unstructured":"Svarstad BL, Chewning BA, Sleath BL, Claesson C (1999) The Brief Medication Questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns 37(2):113\u2013124","journal-title":"Patient Educ Couns"},{"issue":"5","key":"6789_CR44","first-page":"767","volume":"10","author":"V Jim\u00e9nez","year":"1992","unstructured":"Jim\u00e9nez V, ML FF (1992) Descriptive study of patient compliance in pharmacologic antihypertensive treatment and validation of the Morisky and Green test. Atencion Primaria. 10(5):767\u201370","journal-title":"Atencion Primaria."},{"issue":"1","key":"6789_CR45","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1185\/03007990802619425","volume":"25","author":"CA McHorney","year":"2009","unstructured":"McHorney CA (2009) The adherence estimator: a brief, proximal screener for patient propensity to adhere to prescription medications for chronic disease. Curr Med Res Opin 25(1):215\u2013238","journal-title":"Curr Med Res Opin"},{"key":"6789_CR46","unstructured":"Carr A, Hughes R, Vincent K, Carr M, Thwaites C (2004) editors. The impact and implications of new treatments in arthritis: validation of a questionnaire to measure the \u2018real life\u2019effectiveness of medication. rheumatology; oxford univ press great clarendon st, Oxford ox2 6DP, ENGLAND"},{"issue":"2","key":"6789_CR47","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s00198-011-1555-8","volume":"23","author":"V Breuil","year":"2012","unstructured":"Breuil V, Cortet B, Cott\u00e9 F-E, Arnould B, Dias-Barbosa C, Gaudin A-F et al (2012) Validation of the adherence evaluation of osteoporosis treatment (ADEOS) questionnaire for osteoporotic post-menopausal women. Osteoporos Int 23(2):445\u2013455","journal-title":"Osteoporos Int"},{"issue":"7","key":"6789_CR48","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1007\/s11136-014-0662-3","volume":"23","author":"K Reynolds","year":"2014","unstructured":"Reynolds K, Viswanathan HN, Muntner P, Harrison TN, Cheetham TC, Hsu J-WY et al (2014) Validation of the Osteoporosis-Specific Morisky Medication Adherence Scale in long-term users of bisphosphonates. Quality Life Res 23(7):2109\u201320","journal-title":"Quality Life Res"},{"issue":"1","key":"6789_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-7525-2-1","volume":"2","author":"MJ Atkinson","year":"2004","unstructured":"Atkinson MJ, Sinha A, Hass SL, Colman SS, Kumar RN, Brod M et al (2004) Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health Qual Life Outcomes 2(1):1\u201313","journal-title":"Health Qual Life Outcomes"},{"issue":"3","key":"6789_CR50","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0920-9964(99)00130-9","volume":"42","author":"K Thompson","year":"2000","unstructured":"Thompson K, Kulkarni J, Sergejew A (2000) Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr Res 42(3):241\u2013247","journal-title":"Schizophr Res"},{"issue":"1","key":"6789_CR51","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/bcp.12942","volume":"82","author":"M El Alili","year":"2016","unstructured":"El Alili M, Vrijens B, Demonceau J, Evers SM, Hiligsmann M (2016) A scoping review of studies comparing the medication event monitoring system (MEMS) with alternative methods for measuring medication adherence. Br J Clin Pharmacol 82(1):268\u2013279","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"6789_CR52","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2165\/00115677-200715020-00006","volume":"15","author":"J Hawkshead","year":"2007","unstructured":"Hawkshead J, Krousel-Wood MA (2007) Techniques for measuring medication adherence in hypertensive patients in outpatient settings. Dis Manag Health Out 15(2):109\u2013118","journal-title":"Dis Manag Health Out"},{"issue":"2","key":"6789_CR53","doi-asserted-by":"publisher","first-page":"73","DOI":"10.4103\/tcmj.tcmj_177_18","volume":"31","author":"S Basu","year":"2019","unstructured":"Basu S, Garg S, Sharma N, Singh MM (2019) Improving the assessment of medication adherence: challenges and considerations with a focus on low-resource settings. Tzu-Chi Med J 31(2):73","journal-title":"Tzu-Chi Med J"},{"issue":"1","key":"6789_CR54","first-page":"55","volume":"38","author":"J Culig","year":"2014","unstructured":"Culig J, Leppee M (2014) From Morisky to Hill-bone; self-reports scales for measuring adherence to medication. Coll Antropol 38(1):55\u201362","journal-title":"Coll Antropol"},{"issue":"1","key":"6789_CR55","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s11096-013-9865-x","volume":"36","author":"A Lehmann","year":"2014","unstructured":"Lehmann A, Aslani P, Ahmed R, Celio J, Gauchet A, Bedouch P et al (2014) Assessing medication adherence: options to consider. Int J Clin Pharm 36(1):55\u201369","journal-title":"Int J Clin Pharm"},{"issue":"3","key":"6789_CR56","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1210\/jc.2003-030501","volume":"89","author":"JA Clowes","year":"2004","unstructured":"Clowes JA, Peel NF, Eastell R (2004) The impact of monitoring on adherence and persistence with antiresorptive treatment for postmenopausal osteoporosis: a randomized controlled trial. J Clin Endocrinol Metab 89(3):1117\u20131123","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"6789_CR57","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1185\/03007990903126833","volume":"25","author":"S Karve","year":"2009","unstructured":"Karve S, Cleves MA, Helm M, Hudson TJ, West DS, Martin BC (2009) Good and poor adherence: optimal cut-point for adherence measures using administrative claims data. Curr Med Res Opin 25(9):2303\u20132310","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"6789_CR58","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/pds.3935","volume":"25","author":"MJ Bijlsma","year":"2016","unstructured":"Bijlsma MJ, Janssen F, Hak E (2016) Estimating time-varying drug adherence using electronic records: extending the proportion of days covered (PDC) method. Pharmacoepidemiol Drug Saf 25(3):325\u2013332","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"6789_CR59","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s11019-004-0804-4","volume":"7","author":"P Allmark","year":"2005","unstructured":"Allmark P (2005) Bayes and health care research. Med Health Care Philos 7(3):321\u2013332","journal-title":"Med Health Care Philos"},{"issue":"6","key":"6789_CR60","first-page":"499","volume":"6","author":"KA Fairman","year":"2000","unstructured":"Fairman KA, Motheral B (2000) Evaluating medication adherence: which measure is right for your program? J Manag Care Pharm 6(6):499\u2013506","journal-title":"J Manag Care Pharm"},{"issue":"4","key":"6789_CR61","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1111\/bjhp.12332","volume":"23","author":"H Durand","year":"2018","unstructured":"Durand H, Hayes P, Harhen B, Conneely A, Finn DP, Casey M et al (2018) Medication adherence for resistant hypertension: assessing theoretical predictors of adherence using direct and indirect adherence measures. Br J Health Psychol 23(4):949\u2013966","journal-title":"Br J Health Psychol"},{"issue":"7","key":"6789_CR62","first-page":"1546","volume":"18","author":"HG Tegegn","year":"2020","unstructured":"Tegegn HG, D\u2019Espaignet ET, Wark S, Spark MJ (2020) Self-reported medication adherence tools in cardiovascular disease: protocol for a systematic review of measurement properties. JBI Evid Synth 18(7):1546\u20131556","journal-title":"JBI Evid Synth"},{"issue":"3","key":"6789_CR63","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jclinepi.2010.09.002","volume":"64","author":"DE Morisky","year":"2011","unstructured":"Morisky DE, DiMatteo MR (2011) Improving the measurement of self-reported medication nonadherence: response to authors. J Clin Epidemiol 64(3):255\u2013257","journal-title":"J Clin Epidemiol"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-023-06789-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-023-06789-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-023-06789-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T09:03:16Z","timestamp":1692090196000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-023-06789-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,8]]},"references-count":63,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["6789"],"URL":"https:\/\/doi.org\/10.1007\/s00198-023-06789-5","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,8]]},"assertion":[{"value":"30 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This article contains no studies with human or animal subjects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights and informed consent"}}]}}